Editorial: the other bug

Kevin O Turner¹, Robert M Genta^{2

3}

Affiliations

Editorial

Kevin O Turner et al. Aliment Pharmacol Ther. 2023 Jun.

. 2023 Jun;57(12):1465-1466.

doi: 10.1111/apt.17503.

Kevin O Turner¹, Robert M Genta^{2

3}

No abstract available

Comment on

Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease.
Taillieu E, De Witte C, De Schepper H, Van Moerkercke W, Rutten S, Michiels S, Arnst Y, De Bruyckere S, Francque S, van Aert F, George C, Callewaert E, Callewaert T, Vanneste G, Vanderstraeten E, Van Heddegem N, Vansteelant M, Chiers K, Haesebrouck F, Van Steenkiste C. Taillieu E, et al. Aliment Pharmacol Ther. 2023 Jun;57(12):1432-1444. doi: 10.1111/apt.17488. Epub 2023 Mar 28. Aliment Pharmacol Ther. 2023. PMID: 36975151

1. Taillieu E, De Witte C, De Schepper H, Van Moerkercke W, Rutten S, Michiels S, et al. Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease. Aliment Pharmacol Ther. 2023;57:1432-44.
1. Genta RM, Sonnenberg A. Helicobacter-negative gastritis: a distinct entity unrelated to Helicobacter pylori infection. Aliment Pharmacol Ther. 2015;41(2):218-26.
1. Yasuda T, Lee HS, Nam SY, Katoh H, Ishibashi Y, Yamagata Murayama S, et al. Non-Helicobacter pylori Helicobacter (NHPH) positive gastric cancer. Sci Rep. 2022;12:4811. https://doi.org/10.1038/s41598-022-08962-y